-
Mashup Score: 0Patient Information: Huntington Disease - 7 month(s) ago
This JAMA Patient Page describes Huntington disease and its symptoms, diagnosis, prognosis, and treatment options.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 7Home - 8 month(s) ago
This 45-minute roundtable discussion will focus on advances in recognizing and managing Huntington disease chorea, with a particular focus on newer therapies. This activity is intended for neurologists, primary care physicians, nurse practitioners, nurses, physician assistants, and other clinicians who treat patients with Huntington disease (HD). The goal of this activity is for learners to be better able to update clinicians on the latest advancements in HD, including new findings concerning diagnosis,
Source: na.eventscloud.comCategories: General Medicine News, Latest HeadlinesTweet-
📍 Hear the latest updates in #HuntingtonDisease & new treatments for HD chorea from @FurrStimming, @doc4hd & @claassenlabvumc this Monday, August 28th! ➡️ Register today for CME/CE credits & to secure your spot: https://t.co/bWNT4EdkWg #movedisorder #mdscongress #neurology https://t.co/L6Qf5hrrdB
-
📍 Hear the latest updates in #HuntingtonDisease & new treatments for HD chorea from @FurrStimming, @doc4hd & @claassenlabvumc this Monday, August 28th! ➡️ Register today for CME/CE credits & to secure your spot: https://t.co/8pVIuyq0KU #movedisorder #mdscongress #NeuroX #CME https://t.co/bMTVqb2zXT
-
-
Mashup Score: 1Patient Information: Huntington Disease - 8 month(s) ago
This JAMA Patient Page describes Huntington disease and its symptoms, diagnosis, prognosis, and treatment options.
Source: jamanetwork.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet-
Huntington disease is a rare genetic disease that affects movement, thinking, and behavior. This JAMA Patient Page describes #HuntingtonDisease, its symptoms, diagnosis, prognosis, and treatment options. https://t.co/mteRfO4KiW https://t.co/FwrInNEIBJ
-
-
Mashup Score: 0Humanistic Burden of Huntington Disease - 1 year(s) ago
Background and Objectives Huntington disease (HD) is a rare, inherited, and highly complex neurodegenerative disorder with no currently approved disease-modifying treatments. We investigated the effect of HD on health-related quality of life and other patient-reported outcomes in the Huntington’s Disease Burden of Illness (HDBOI) study. Methods The HDBOI study is a retrospective, cross-sectional…
Source: Neurology Clinical PracticeCategories: Latest Headlines, NeurologyTweet-
The Huntington Disease Burden of Illness Study study provides new insights into the characteristics and humanistic burden of people with HD and offers a meaningful contribution to this underserved research area. Learn more: https://t.co/ohwK56JaKI #NeuroTwitter #HuntingtonDisease https://t.co/cx7NWzYWYY
-
-
Mashup Score: 1Gene Therapy for Huntington Disease Was Safe and Decreased Biomarkers in Clinical Trial - Practical Neurology - 2 year(s) ago
In a phase 1 /2 clinical trial (NCT04120493), 10 participants with early stage Huntington disease were treated with a low dose of gene therapy (AMT-13
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet-
Gene Therapy for Huntington Disease Was Safe and Decreased Biomarkers in Clinical Trial #neurology #huntingtondisease #PracticalNeurology https://t.co/ngSye9ZS1V
-
-
Mashup Score: 0First-Ever Huntington Staging System May Spur Drug Development - 2 year(s) ago
The first-ever staging system for Huntington disease is a key step toward developing drugs that target the disorder before the onset of debilitating symptoms.
Source: MedscapeCategories: Latest Headlines, NeurologyTweet-
The first-ever staging system for #Huntingtondisease is a key step toward developing drugs that target the disorder before the onset of debilitating symptoms. https://t.co/83JrQgPXdh
-
-
Mashup Score: 1
Valbenazine (Ingrezza; Neurocrine Biosciences, San Diego, CA) is the only selective vesicular monoamine transporter 2 (VMAT2) inhibitor approved for t
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet-
#Valbenazine Shows Efficacy for Chorea in Huntington Disease and Is Safe and Effective for Treatment of Tardive Dyskinesia in People Over Age 65 #huntingtondisease #neurology #PracticalNeurology https://t.co/hNFErimd7M
-
-
Mashup Score: 1A New Phase 2 Trial of Tominersen for Early Huntington Disease Designed - Practical Neurology - 2 year(s) ago
A new phase 2 trial is planned to evaluate tominersen (IONIS-HTTRx; Ionis Pharmaceuticals, Carlsbad, CA) to treat early-stage Huntington disease (HD).
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet-
A New Phase 2 Trial of #Tominersen for Early Huntington Disease Designed #neurology #huntingtondisease #PracticalNeurology https://t.co/BdfSxWL5e5
-
-
Mashup Score: 7Huntington Disease Trial of New Antisense Oligonucleotide Therapy Begins Dosing - Practical Neurology - 3 year(s) ago
The first participant has been treated in the phase 1b/2a SELECT-HD clinical trial evaluating an investigational stereopure antisense oligonucleotide
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet-
Huntington Disease Trial of New Antisense Oligonucleotide Therapy Begins Dosing #neurology #brain #huntingtondisease #PracticalNeurology https://t.co/5lZxse8mHR
-
-
Mashup Score: 5Huntington Disease Trial of New Antisense Oligonucleotide Therapy Begins Dosing - Practical Neurology - 3 year(s) ago
The first participant has been treated in the phase 1b/2a SELECT-HD clinical trial evaluating an investigational stereopure antisense oligonucleotide
Source: Practical NeurologyCategories: Latest Headlines, NeurologyTweet-
Huntington Disease Trial of New Antisense Oligonucleotide Therapy Begins Dosing #neurology #HD #huntingtondisease #PracticalNeurology https://t.co/o2O7y1G0M3
-
Huntington disease is a rare genetic disease that affects movement, thinking, and behavior. This JAMA Patient Page describes #HuntingtonDisease, its symptoms, diagnosis, prognosis, and treatment options. https://t.co/okvwhtnD06 https://t.co/LaxKRhixQA